|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
c.978C>A |
1206C>A |
p.S326R |
0.00058 |
1 - Not pathogenic or of no clinical significance |
Spearman AD et al., J Clin Oncol, 26:5393-5400, 2008. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
- |
3.61 |
7.92 |
0.001 |
- |
0.02859 |
- |
10 |
c.1151C>T |
1379C>T |
p.S384F |
0.00042 |
1 - Not pathogenic or of no clinical significance |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.0987 |
- |
- |
0.2104 |
- |
0.02077 |
- |
10 |
c.1804G>A |
2032G>A |
p.G602R |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.00026 |
- |
0.129 |
1.479 |
- |
4.96057E-5 |
- |
11 |
c.2606C>T |
2834C>T |
p.S869L |
0.1037 |
3 - Uncertain |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
9.43 |
0.52 |
- |
1.156 |
- |
5.66856 |
- |
11 |
c.2786T>C |
3014T>C |
p.L929S |
0.00007 |
1 - Not pathogenic or of no clinical significance |
Spearman AD et al., J Clin Oncol, 26:5393-5400, 2008. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
- |
0.73 |
4.97 |
0.001 |
- |
0.00363 |
- |
11 |
c.3793T>A |
4021T>A |
p.C1265S |
0.00088 |
1 - Not pathogenic or of no clinical significance |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.042 |
- |
- |
1.0294 |
- |
0.04323 |
- |
11 |
c.4258G>T |
4486G>T |
p.D1420Y |
0.00010 |
1 - Not pathogenic or of no clinical significance |
Spearman AD et al., J Clin Oncol, 26:5393-5400, 2008. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.02 |
0.00 |
0.02 |
- |
1.11 |
4.52 |
0.001 |
- |
0.00502 |
- |
11 |
c.6821G>T |
7049G>T |
p.G2274V |
0.0117 |
2 - Likely not pathogenic or of little clinical significance |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.215 |
1.2 |
- |
2.249 |
- |
0.58024 |
- |
13 |
c.6953G>A |
7181G>A |
p.R2318Q |
0.00265 |
2 - Likely not pathogenic or of little clinical significance |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.1264 |
- |
- |
1.0294 |
- |
0.13012 |
- |
18 |
c.7994A>G |
8222A>G |
p.D2665G |
0.0183 |
2 - Likely not pathogenic or of little clinical significance |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.81 |
0.01 |
0.00 |
0.81 |
0.0021 |
1.2 |
- |
1.733 |
- |
0.00437 |
- |
20 |
c.8567A>C |
8795A>C |
p.E2856A |
0.0398 |
2 - Likely not pathogenic or of little clinical significance |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.03 |
0.01 |
0.00 |
0.03 |
1.05 |
1.2 |
- |
1.064 |
- |
1.34064 |
- |
22 |
c.8905G>A |
9133G>A |
p.V2969M |
0.00001 |
1 - Not pathogenic or of no clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.03 |
0.01 |
0.00 |
0.03 |
0.269 |
- |
0.00871 |
0.151 |
- |
0.00035 |
- |
24 |
c.9155G>A |
9383G>A |
p.R3052Q |
0.00544 |
2 - Likely not pathogenic or of little clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.66 |
0.01 |
0.00 |
0.66 |
1 |
- |
0.0575 |
0.049 |
- |
0.00282 |
- |
24 |
c.9235G>A |
9463G>A |
p.V3079I |
0.00002 |
1 - Not pathogenic or of no clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.03 |
0.01 |
0.00 |
0.03 |
1 |
- |
0.158 |
0.00417 |
- |
0.00066 |
- |
25 |
c.9275A>G |
9503A>G |
p.Y3092C |
0.0250 |
2 - Likely not pathogenic or of little clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.81 |
0.01 |
0.00 |
0.81 |
1.023 |
- |
0.00457 |
1.2883 |
- |
0.00602 |
- |
25 |
c.9292T>C |
9520T>C |
p.Y3098H |
0.00001 |
1 - Not pathogenic or of no clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.03 |
0.01 |
0.00 |
0.03 |
5.012 |
- |
0.00035 |
0.195 |
- |
0.00034 |
- |
26 |
c.9509A>G |
9737A>G |
p.D3170G |
0.00003 |
1 - Not pathogenic or of no clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.03 |
0.01 |
0.00 |
0.02 |
0.038 |
- |
0.0288 |
1.175 |
- |
0.00129 |
- |
27 |
c.10045A>G |
10273A>G |
p.T3349A |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton DF et al., Am J Hum Genet, 81: 873-883, 2007. |
Tavtigian et al., Human Mutation 29: 1342-1354, 2008. |
0.02 |
0.01 |
0.00 |
0.02 |
0.0004 |
- |
0.195 |
0.0589 |
- |
4.59420E-6 |
- |